HOME >> MEDICINE >> NEWS
Promising drug fails to thwart fatal lung disease in large trial

DURHAM, N.C. -- A treatment that had shown early promise in alleviating symptoms and preventing the advance of the fatal lung disease pulmonary fibrosis failed to stall the disorder's progression in 162 patients, according to the results of an international clinical trial reported in the Jan. 8, 2004, issue of The New England Journal of Medicine.

Despite the treatment's failure to prevent scarring of the lungs -- a defining characteristic of the disease -- results of the trial did suggest that the drug, known as interferon gamma-1b, might extend the lives of select patients with mild to moderate symptoms, said pulmonologist David A. Schwartz, M.D., who led a portion of the trial at Duke University Medical Center.

"The bottom-line is that interferon gamma does not appear to be effective in slowing progression of pulmonary fibrosis (PF), but could potentially improve survival in patients if caught early in the disease process," Schwartz said.

The study was funded by InterMune Pharmaceuticals, Inc, Brisbane, CA, which manufactures interferon gamma-1b. Dr. Schwartz has been a paid consultant for InterMune since 2000.

PF is an inflammatory disease that results in scarring, or fibrosis, of the lungs. Over time, the fibrosis can progress such that the lungs can no longer deliver oxygen to the body's tissues. Although physicians often treat the disorder with a combination of anti-inflammatory and immunosuppressive therapies, the only clearly effective treatment is lung transplantation, Schwartz said. The median survival time for patients with the disease is two to three years.

PF has multiple causes including exposure to environmental contaminants, such as cigarette smoke and asbestos, and genetic predisposition. The prevalence of the disease is unknown according the National Institutes of Health, but estimates indicate the numbers are rising with as many as 15,000 new cases of idiopathic PF -- a form of the disease having unkno
'"/>

Contact: Kendall Morgan
kendall.morgan@duke.edu
919-684-4148
Duke University Medical Center
7-Jan-2004


Page: 1 2 3

Related medicine news :

1. Promising new strategy for Swedish medical research
2. Promising treatments for Huntingtons disease identified in UCI study
3. Promising results for malaria vaccine trial
4. Promising diagnostic test for sleeping sickness
5. Promising new treatment options for people with co-existing alcohol-use and psychiatric disorders
6. Promising drug proves ineffective as treatment for hearing loss
7. Promising West Nile virus vaccine protects monkeys
8. Promising new treatment preserves bone mass in mice; May help women and men with osteoporosis
9. Promising vaccine may provide long-lasting protection against malaria
10. Promising new research on schizophrenia causes
11. UI Study Suggests Promising Treatment For Diabetic Pregnancies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2019)... ... March 20, 2019 , ... ... Crominex®3+, a composition of trivalent chromium chloride combined with extracts of amla and ... This newly granted patent, along with 7 clinical studies on Crominex®3+, establish this ...
(Date:3/20/2019)... ... March 20, 2019 , ... James ... and Biosciences (KCU) as vice provost for oral health initiatives. Koelbl will assist ... College of Dental Medicine on the university’s Joplin, Missouri, campus. The proposed program ...
(Date:3/20/2019)... ... March 20, 2019 , ... AutismOne has announced that Dr. Andrew Wakefield, an ... measles. Dr. Wakefield's presentation at the AutismOne 2019 Conference will address what herd immunity ... eras. The lecture will examine the consequences - real and potential - for vaccines ...
(Date:3/20/2019)... ... 20, 2019 , ... The Center for Advancing Innovation (CAI), ... open innovation contest to advance high-impact inventions and solutions to defeat brain tumors. ... will launch 15+ startups to commercialize promising drugs, devices, diagnostics, and digital health ...
(Date:3/19/2019)... ... March 19, 2019 , ... Adult superstar, sex educator and exclusive Wicked ... to Wicked Sex: Senior Sex’ will begin production on April 17 in Los Angeles. ... newest edition of “Guide to Wicked Sex” brings together jessica drake with senior sex ...
Breaking Medicine News(10 mins):
(Date:3/20/2019)... ... March 20, 2019 , ... Aeroflow Healthcare, an Inc. 5000 ... from April 22-26, during national Every Kid Healthy™ Week, to benefit Diaper Bank of ... of diapers at Aeroflow’s headquarters at 3165 Sweeten Creek Road in Asheville, N.C. Diapers ...
(Date:3/20/2019)... ... 2019 , ... 1888 Mills is announcing a new line ... – that will keep fabrics fresher and clean smelling longer. The products, including ... brand offerings, such as the 1888 Mills’ new Freshee™ line, along with private ...
(Date:3/20/2019)... Ala. (PRWEB) , ... March 20, 2019 , ... ... to help its adult residential services’ patients Stay Active & Independent for Life ... exercises that improve strength, balance, and fitness can help adults stay active and ...
Breaking Medicine Technology:
Cached News: